1. Home
  2. SLDP vs IVA Comparison

SLDP vs IVA Comparison

Compare SLDP & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDP
  • IVA
  • Stock Information
  • Founded
  • SLDP 2011
  • IVA 2011
  • Country
  • SLDP United States
  • IVA France
  • Employees
  • SLDP N/A
  • IVA N/A
  • Industry
  • SLDP Electrical Products
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLDP Energy
  • IVA Health Care
  • Exchange
  • SLDP Nasdaq
  • IVA Nasdaq
  • Market Cap
  • SLDP 645.4M
  • IVA 769.0M
  • IPO Year
  • SLDP N/A
  • IVA 2020
  • Fundamental
  • Price
  • SLDP $5.69
  • IVA $5.82
  • Analyst Decision
  • SLDP Strong Buy
  • IVA Strong Buy
  • Analyst Count
  • SLDP 1
  • IVA 7
  • Target Price
  • SLDP $4.00
  • IVA $16.57
  • AVG Volume (30 Days)
  • SLDP 17.1M
  • IVA 127.7K
  • Earning Date
  • SLDP 11-04-2025
  • IVA 09-29-2025
  • Dividend Yield
  • SLDP N/A
  • IVA N/A
  • EPS Growth
  • SLDP N/A
  • IVA N/A
  • EPS
  • SLDP N/A
  • IVA N/A
  • Revenue
  • SLDP $22,667,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • SLDP $27.38
  • IVA N/A
  • Revenue Next Year
  • SLDP $37.97
  • IVA N/A
  • P/E Ratio
  • SLDP N/A
  • IVA N/A
  • Revenue Growth
  • SLDP 14.83
  • IVA N/A
  • 52 Week Low
  • SLDP $0.68
  • IVA $2.11
  • 52 Week High
  • SLDP $8.05
  • IVA $6.55
  • Technical
  • Relative Strength Index (RSI)
  • SLDP 54.27
  • IVA 55.92
  • Support Level
  • SLDP $5.49
  • IVA $4.96
  • Resistance Level
  • SLDP $6.75
  • IVA $5.34
  • Average True Range (ATR)
  • SLDP 0.96
  • IVA 0.46
  • MACD
  • SLDP -0.05
  • IVA 0.00
  • Stochastic Oscillator
  • SLDP 38.20
  • IVA 70.10

About SLDP Solid Power Inc.

Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: